FDA NDC Directory · JSON-LD · Markdown

Divalproex Sodium

NDC 0832-7123 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Labeler / ManufacturerUpsher-Smith Laboratories, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA078182
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsDIVALPROEX SODIUM (250 mg/1)
Marketing started20140321
Marketing ended20271031
Package count3

External sources

Source: openFDA. Public-domain (CC0).